FUNDING
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Emulate Closes $82 Million Series E Financing to Scale Amid Rapid Growth in Organ-on-a-Chip Market
The funds raised through the Series E financing round will support a significant scale-up in research and development activities to facilitate the creation of new human-relevant organ-on-a-chip models in immunology, neuroinflammation, tumor modeling, and more.
Bioventus Invests in Trice Medical Minimally Invasive Technologies
“Trice’s established and growing presence in sports medicine and orthopedics is directly aligned with our strategy of expanding our offerings across these core Bioventus call points,” said Chris Yamamoto, Senior Vice President of Business Development & Strategy, Bioventus.
Speclipse Attracts $7.7M In Investments
Signite Partners, BNH Investment, Shinhan Capital, and MiCo, who just secured the status of major shareholders earlier this year, were the main contributors to the latest Speclipse investment. MiCoBioMed, an affiliate of MiCo, also contributed funds to support Speclipse's growth.
Ultromics Raises $33M Series B Funding Led by Blue Venture Fund
Led by Blue Venture Fund, new funding will accelerate Ultromics' use of AI-enabled echocardiograms to improve patient outcomes.
BrainQ $40M Funding Round to Support Multicenter Pivotal Trial
The funding will be used to support a multicenter pivotal trial for its groundbreaking technology for ischemic stroke survivors in selected US hospitals.
HAGAR Secures $11.7M Series B Funding To Develop Clinical Trials
The round was led by a returning investor, Columbia Pacific. This investment brings HAGAR’s total funding to $17.1 million, following the $4.4 million in Series A funding it received in March 2021.
Append Medical Completes $7.4M Million Series A Round
Funding will support the company’s first clinical trial on its path to regulatory clearance.
MiRus™ Raises $65 Million For Expansion of Rhenium-based Medical Devices
MiRus spine implants are distributed through leading hospitals and surgery centers around the country.
Biospectal Raises $4.3M Seed Funding Led by Digital Health Investor, SeedLink
“Biospectal OptiBP is a breakthrough technology that enables more accessible, effective, and efficient patient monitoring to empower patients to contribute to, and participate in, the clinical regimen for chronic condition monitoring and management,” said Tim Juergens, General Manager, and co-founder, SeedLink.
Medical Device News Magazine
